- Q&A: Novo research chief Petersen says streamlined R&D speeds discoveryJust as Maziar Mike Doustdar took the helm at Novo Nordisk in the summer of 2025, the company said it would reorganize its R&D activities, merging the teams that focused on early ...Endpoints · 2mo ago↗ source
- Wave aims for monthly dosing with RNA editing treatment for AATDWave Life Sciences reported an updated cut of data from its early-stage study of an RNA editing treatment for alpha-1 antitrypsin deficiency, suggesting it can dose its genetic therapy monthly. P…Endpoints · 2mo ago↗ source
- A migraine drugmaker heads to the public markets through reverse merger<figure><div><img src="https://imgproxy.divecdn.com/0Yf4L7bvFRwsrMG85EgRSmundmb9MCnHWX_B23e8BPk/g:nowe:0:0/c:3000:1694/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0…